Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8597
- By:
- Publication type:
- Article
Works matching IS 1021335X AND DT 2023 AND VI 50 AND IP 2
Results: 14
1
2
[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8596
- By:
- Publication type:
- Article
3
[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8595
- By:
- Publication type:
- Article
4
GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8594
- By:
- Publication type:
- Article
5
Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8598
- By:
- Publication type:
- Article
6
[Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8593
- By:
- Publication type:
- Article
7
Effects of autophagy‑related gene 5 on tumor development and treatment (Review).
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8592
- By:
- Publication type:
- Article
8
Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8591
- By:
- Publication type:
- Article
9
[Retracted] MicroRNA‑9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8590
- By:
- Publication type:
- Article
10
NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8589
- By:
- Publication type:
- Article
11
[Retracted] CtBP1 interacts with SOX2 to promote the growth, migration and invasion of lung adenocarcinoma.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8588
- By:
- Publication type:
- Article
12
Downregulation of fascin induces collective cell migration in triple‑negative breast cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8587
- By:
- Publication type:
- Article
13
[Corrigendum] Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8586
- By:
- Publication type:
- Article
14
The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
- Published in:
- Oncology Reports, 2023, v. 50, n. 2, p. N.PAG, doi. 10.3892/or.2023.8585
- By:
- Publication type:
- Article